Prediction is difficult, particularly about the future

Archives of Internal Medicine

Volumn 167, Issue 21, 2007, Pages 2286-2287

  Jackson, Rod ^a   Wells, Sue ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; EDITORIAL; HUMAN; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT;

ANTILIPEMIC AGENTS; CORONARY DISEASE; DYSLIPIDEMIAS; HUMANS; LIFE STYLE; LIPIDS; MIDDLE AGED; RISK FACTORS;

EID: 36549061909     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.21.2286     Document Type: Editorial

References (6)

1. Jackson R, Lawes C, Bennett D, Milne R, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet. 2005;365(9457):434-441.
2. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121(1, pt 2):293-298.
3. Whittaker R, Bramley D, Wells S, et al. Will a web-based cardiovascular disease (CVD) risk assessment programme increase the assessment of CVD risk factors for Maori? N Z Med J. 2006;119(1238):U2077.
4. Grover SA, Lowensteyn I, Joseph L, et al; for the Cardiovascular Health Evaluation to Improve Compliance and Knowledge Among Uninformed Patients (CHECK-UP) Study Group. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP Study: a randomized controlled trial. Arch Intern Med. 2007;167(21):2296-2303.
5. Mann JI, Crooke M, Fear H, et al. Guidelines for detection and management of dyslipidaemia. N Z Med J. 1993;106(953):133-142.
6. Garg AX, Adhikari NKJ, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293(10):1223-1238.